Blackstone Inc Portfolio holdings
AUM
$22.2B
1-Year Return
35.09%
This Quarter Return
+4.93%
1 Year Return
+35.09%
3 Year Return
+97.31%
5 Year Return
+254.01%
10 Year Return
+403.63%
AUM
$22B
AUM Growth
-$500M
(-2.2%)
Cap. Flow
-$1.15B
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
70.29%
Holding
192
New
18
Increased
33
Reduced
43
Closed
30
Top Buys
| 1 |
Loar Holdings
LOAR
|
$864M |
| 2 |
TC Energy
TRP
|
$165M |
| 3 |
Williams Companies
WMB
|
$115M |
| 4 |
NextEra Energy, Inc.
NEE
|
$96.1M |
| 5 |
Western Midstream Partners
WES
|
$79.8M |
Top Sells
| 1 |
PG&E
PCG
|
$740M |
| 2 |
Gates Industrial
GTES
|
$536M |
| 3 |
Mid-America Apartment Communities
MAA
|
$294M |
| 4 |
Targa Resources
TRGP
|
$249M |
| 5 |
Energy Transfer Partners
ET
|
$222M |
Sector Composition
| 1 | Energy | 68.16% |
| 2 | Financials | 9.29% |
| 3 | Utilities | 7.22% |
| 4 | Industrials | 6.27% |
| 5 | Real Estate | 2.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Amicus Therapeutics
FOLD
$2.47B
| $26.3M | 0.11% |
2,467,104
| – | – |
|
52
TransUnion
TRU
$17.3B
| $26.2M | 0.11% |
250,000
-290,000
| -54% | -$30.4M |
|
53
Antero Midstream
AM
$8.65B
| $26M | 0.11% |
1,725,890
+1,004,085
| +139% | +$15.1M |
|
54
USA Compression Partners
USAC
$2.92B
| $24.3M | 0.11% |
1,061,791
+44,316
| +4% | +$1.02M |
|
55
VanEck Gold Miners ETF
GDX
$19.4B
| $23.9M | 0.1% |
+600,000
| New | +$23.9M |
|
56
MindMed
MNMD
$702M
| $22.3M | 0.1% |
3,912,479
+2,014,154
| +106% | +$11.5M |
|
57
Bridger Aerospace
BAER
$108M
| $21.4M | 0.09% |
9,624,610
| – | – |
|
58
Compass Therapeutics
CMPX
$466M
| $18.4M | 0.08% |
10,025,151
+2,333,590
| +30% | +$4.29M |
|
|
HPP
59
Hudson Pacific Properties
HPP
$1.08B
| $18.2M | 0.08% |
3,797,100
| – | – |
|
60
Kinder Morgan
KMI
$59.4B
| $18M | 0.08% |
814,593
+425,000
| +109% | +$9.39M |
|
61
GeneDx Holdings
WGS
$3.74B
| $17.9M | 0.08% |
420,715
-414,347
| -50% | -$17.6M |
|
|
LINE
62
Lineage, Inc. Common Stock
LINE
$9.26B
| $17.8M | 0.08% |
+227,500
| New | +$17.8M |
|
|
ABVX
63
Abivax
ABVX
$6.47B
| $17.5M | 0.08% |
1,522,434
-339,603
| -18% | -$3.91M |
|
|
BCAX
64
Bicara Therapeutics Inc. Common Stock
BCAX
$658M
| $16.6M | 0.07% |
+650,000
| New | +$16.6M |
|
65
Archrock
AROC
$4.47B
| $16M | 0.07% |
789,763
-21,419
| -3% | -$434K |
|
|
CLDT
66
Chatham Lodging
CLDT
$369M
| $13.8M | 0.06% |
1,621,000
| – | – |
|
67
Comfort Systems
FIX
$25.5B
| $13.7M | 0.06% |
35,000
-65,000
| -65% | -$25.4M |
|
68
Array Technologies
ARRY
$1.39B
| $11.9M | 0.05% |
1,799,900
| – | – |
|
69
Core Scientific
CORZ
$4.16B
| $11.9M | 0.05% |
+1,000,000
| New | +$11.9M |
|
70
UL Solutions
ULS
$12.7B
| $11.1M | 0.05% |
225,000
| – | – |
|
71
Lexeo Therapeutics
LXEO
$268M
| $10.5M | 0.05% |
1,158,617
+352,860
| +44% | +$3.19M |
|
72
SPDR S&P Biotech ETF
XBI
$5.28B
| $10.1M | 0.04% |
102,030
| – | – |
|
73
PennyMac Financial
PFSI
$5.96B
| $9.69M | 0.04% |
+85,000
| New | +$9.69M |
|
74
Enliven Therapeutics
ELVN
$1.19B
| $9.53M | 0.04% |
373,323
+52,143
| +16% | +$1.33M |
|
75
Spyre Therapeutics
SYRE
$1.03B
| $8.62M | 0.04% |
292,995
| – | – |
|